ESC 365 - Clinical residual cardiovascular risk: what are the markers?

EAPC Premium Access

Clinical residual cardiovascular risk: what are the markers?

Session: Inflammation in atherosclerosis: translating science into practicable solutions.

Topic: Secondary Prevention

Speaker: Professor W. Koenig (Munich, DE)

Sponsored by Novartis Pharma AG

Event: EuroPrevent 2018

Congress Presentation

Add to my library

About the speaker

Professor Wolfgang Koenig

German Heart Center of Munich, Munich (Germany)

24 presentations

0 follower

4 more presentations in this session

Welcome and introduction - Inflammation in atherosclerosis: translating science into practicable solutions.

Speaker: Professor U. Landmesser (Berlin, DE)

Inflammation in atherosclerosis: translating science into practicable solutions.

Speaker: Professor P. Libby (Boston, US)

Advancing standard of care in post-myocardial infarction (MI) patients with elevated high sensitivity C-reactive protein (hsCRP).

Speaker: Professor U. Landmesser (Berlin, DE) Professor P. Libby (Boston, US) Professor W. Koenig (Munich, DE)

Summary and closure - Inflammation in atherosclerosis: translating science into practicable solutions.

Speaker: Professor U. Landmesser (Berlin, DE)

Access the full session

Inflammation in atherosclerosis: translating science into practicable solutions.

Speakers: Professor W. Koenig, Professor U. Landmesser, Professor P. Libby, Professor U. Landmesser, Professor P. Libby...

About the event

EuroPrevent 2018

19 April - 21 April 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources